This is a group of inherited conditions that cause the body's immune system to overreact, leading to repeated episodes of inflammation. Think of it like a faulty switch that keeps the body's defense system turned on too much. Symptoms can include fever, skin rashes, joint pain, and feeling very tired. These conditions are caused by changes in specific genes, not by the body attacking itself.
Every report comes from a Lived member, sent anonymously.
Have you tried Colchicine for Hereditary Autoinflammatory Diseases?
Hereditary autoinflammatory diseases are a group of rare, inherited conditions in which the body's built-in, first-line defenses (the innate immune system) switch on inflammation without a real threat to fight. The result is repeated attacks of fever and inflammation, or in some forms inflammation that never fully settles. Depending on the type, attacks can bring belly or chest pain, swollen joints, rashes, red eyes, muscle aches and deep tiredness. These conditions differ from autoimmune diseases such as lupus, where the immune system makes antibodies or targeted cells against the body's own tissues. In autoinflammatory diseases, that targeted part of the immune system is not the main driver. More than 60 single-gene forms are known. The most common is familial Mediterranean fever (FMF), which causes attacks lasting about half a day to three days. Others include the cryopyrin-associated periodic syndromes (CAPS), TNF receptor-associated periodic syndrome (TRAPS) and mevalonate kinase deficiency (MKD, also called hyper-IgD syndrome). Each has its own pattern of symptoms, age of onset and treatment. These diseases matter beyond the attacks themselves. Inflammation that is not controlled over years can lead to amyloidosis, in which an inflammation-related protein builds up in organs, especially the kidneys, and can cause kidney failure. Some types can also cause hearing loss.
Each of these diseases is caused by a change (variant) in a single gene that helps switch inflammation on or off. The inheritance pattern depends on the type. FMF and MKD are usually recessive: a person inherits an altered copy of the gene from each parent, and the parents themselves are typically healthy carriers. CAPS and TRAPS are usually dominant, so one altered copy is enough and the condition may appear in a parent and child. A family history of unexplained recurrent fevers is a clue, though it is not always present. Some types are more common in particular ancestries. FMF mainly affects people with roots in the eastern Mediterranean, including Armenian, Arab, Turkish and Jewish families, although it is now diagnosed worldwide. The gene change is the cause; triggers only set off individual attacks. Many attacks come with no obvious trigger, but physical or emotional stress, infections, injury, hormonal changes such as menstruation, cold exposure and vaccination can bring them on in some people. Cold is a characteristic trigger for one form of CAPS. Avoiding triggers can help but cannot replace treatment of the underlying disease.
There is no single test that confirms most of these diseases. Diagnosis starts with the pattern: how old the person was when attacks began, how long each attack lasts, how often attacks come, what symptoms appear with them and whether relatives have similar problems. Because these details are easy to forget, clinicians often ask people to keep a diary of each episode. Infections, autoimmune diseases and cancers that can also cause repeated fevers need to be ruled out first. Blood tests taken during an attack usually show high levels of inflammation markers such as C-reactive protein (CRP) and serum amyloid A (SAA). Repeating them between attacks shows whether inflammation is quietly continuing, which matters for long-term risk. A urine test for protein screens for early kidney damage from amyloidosis, and for suspected MKD a urine test during an attack can look for mevalonic acid. Genetic testing, usually a panel that checks many relevant genes at once, is recommended when the pattern fits. A result is not always clear-cut. Some variants are harmless, some people with a disease-causing variant have mild or no symptoms, and some people with a clear clinical picture have no variant found. Interpreting results is best done with a specialist team, usually rheumatology and genetics. For FMF, a good response to a trial of colchicine also supports the diagnosis. Because the symptoms overlap with common illnesses, many people go years before being diagnosed. Painful FMF attacks have even led to unnecessary abdominal surgery when they were mistaken for appendicitis.
Treatment has two goals: to prevent or shorten attacks, and to keep inflammation low between attacks so that long-term damage such as amyloidosis does not develop. For most types, effective treatment now exists, although it controls the disease rather than curing it. For FMF, colchicine, an anti-inflammatory medicine taken by mouth every day, is the first choice. It usually stops attacks or makes them much milder and less frequent, and it prevents kidney amyloidosis. It works only if taken consistently, including when someone feels well. Stomach upset such as diarrhea, cramping and nausea is the most common side effect and often improves with dose changes. Colchicine can have dangerous interactions with some other medicines, including certain antibiotics such as clarithromycin and the transplant drug cyclosporine, and an overdose can be fatal, so any new prescription should be checked against it and supplies kept away from children. Interleukin-1 (IL-1) is one of the main chemical signals driving inflammation in these diseases, and medicines that block it have transformed care. Canakinumab (Ilaris) is approved for CAPS, TRAPS, MKD and FMF that does not respond to colchicine. Anakinra (Kineret) is approved for the most severe form of CAPS and for deficiency of the interleukin-1 receptor antagonist (DIRA), a rare condition in which the body lacks its natural IL-1 brake. Rilonacept (Arcalyst) is approved for CAPS and DIRA. All are given by injection under the skin, on schedules ranging from daily (anakinra) to weekly (rilonacept) to every four to eight weeks (canakinumab). Because they dampen part of the immune response, they raise the risk of serious infections. Vaccinations are usually brought up to date before starting, and live vaccines are avoided during treatment. Nonsteroidal anti-inflammatory drugs such as ibuprofen can ease pain during an attack, and short courses of steroids are sometimes used for particular types, but these do not prevent long-term complications. Treatment is usually guided by a rheumatologist with experience in these rare diseases.
These are lifelong conditions, but with the right treatment many people have few or no attacks and lead full lives at school, at work and in family life. How the disease behaves varies a great deal by type and from person to person. FMF attacks often begin in childhood or the teenage years, while some other types start in infancy. Between attacks, people with FMF usually feel well; some other forms cause more continuous symptoms such as fatigue and rash. Regular follow-up is a central part of living with these diseases. Visits typically review how often attacks happen, check inflammation markers between attacks, test urine for protein and look for side effects of treatment. People with CAPS may also need periodic hearing and eye checks. The aim is not just fewer attacks but no hidden ongoing inflammation, because that is what drives amyloidosis. Planning matters at certain times. Anyone considering pregnancy should review their medicines with their specialist beforehand. Families may also want genetic counseling to understand the chance of passing the condition on and whether relatives should be tested.
Arrange an evaluation if you or your child have repeated episodes of fever with belly or chest pain, joint swelling, rash or red eyes that keep coming back without a clear infection, especially if relatives have a similar history. If you already have a diagnosis, see your specialist when attacks become more frequent or severe despite treatment, or when side effects make it hard to keep taking your medicine. Contact your care team promptly if you take an IL-1 blocking medicine and develop signs of infection, or a fever that feels different from your usual attacks. Seek same-day medical care for belly pain that is much worse than usual, unlike your typical attacks or lasting well beyond their usual length, since appendicitis and other causes can look similar.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hereditary Autoinflammatory Diseases is like, what's helped you, or ask the community a question.